Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...
The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...
Booster doses of the original monovalent COVID-19 vaccine are associated with lower incidence of symptoms in health care personnel 6 weeks postinfection.
In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...
Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...
But COVID-19 tends to jump in the winter months ... The Pfizer and Moderna shots are formulated against a virus subtype ...
The authors said the main outcomes of the study were reactogenicity, including fever, chills, muscle aches, and/or joint pain ...
Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...
The rapid development of COVID-19 vaccines has been instrumental in controlling the spread and severity of severe acute ...
The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...
The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.